Nexalin Technology Inc. (NXL) is a medical devices company listed on NASDAQ.
Latest reported NXL revenue for 2025-12-31 was $301.6K. Net income was -$8.2M. Revenue was up 78.8% from 2024-12-31 to 2025-12-31. NXL currently screens at market cap $8.5M.
Use this NXL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NXL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NXL SEC filings page. Lician reads the product cache first so this HTML stays unique to Nexalin Technology Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full NXL income, balance, and cash tables.